Taking into consideration that impaired adiponectin signaling is a common consequence of obesity and this adipokine prevents some malignant metabolic phenotypes of tumor cells, adiponectin mimic therapy might be another therapeutic strategy for obesity-linked cancer. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.